Journal article
Considerations for the definition of remission criteria in psoriatic arthritis
- Abstract:
-
Objectives
Psoriatic arthritis (PsA) is an autoimmune disease that can cause progressive structural damage of the joints and irreversible disability. The potentially achievable results of biologic therapy for PsA has led to the view that disease remission should be the goal of treatment. However, the heterogeneity of disease manifestations and need for validated outcome measures makes defining remission in PsA challenging. This article evaluates proposed criteria for defining rem...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 351.7KB)
-
- Publisher copy:
- 10.1016/j.semarthrit.2017.10.021
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Novartis Pharmaceuticals Corporation
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Seminars in Arthritis and Rheumatism Journal website
- Volume:
- 47
- Issue:
- 6
- Pages:
- 786-796
- Publication date:
- 2017-10-31
- Acceptance date:
- 2017-10-31
- DOI:
- EISSN:
-
1532-866X
- ISSN:
-
0049-0172
- Pmid:
-
29566966
- Source identifiers:
-
832067
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:832067
- UUID:
-
uuid:8838bdcd-c45b-492c-b605-b39765753bcb
- Local pid:
- pubs:832067
- Deposit date:
- 2018-05-30
Terms of use
- Copyright holder:
- *Copyright holder name ("et al" as required)*
- Copyright date:
- 2017
- Notes:
- © 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
If you are the owner of this record, you can report an update to it here: Report update to this record